Registry of outcomes and practices for extremely premature infants

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Tiny Baby Collaborative Multicenter Inventory of Neonatal-Perinatal Interventions (MINI) minimum dataset aims to create a comprehensive registry that details the outcomes and practices for all deliveries and infants admitted to intensive care at 22-23 weeks' gestation across participating hospitals. This observational study collects baseline data on mothers and infants, including demographics, health status, medical interventions, and clinical outcomes. The collected data will be utilized for quality improvement reporting, evaluating associations between characteristics and outcomes, and tracking trends in neonatal care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All local births with gestational ages of 22 weeks 0 days - 23 weeks 6 days, regardless of pregnancy outcome or neonatal intensive care (NICU) admission; AND
* All outborn NICU admissions with gestational age at birth of 22 weeks 0 days - 23 weeks 6 days
* Optional: Centers who desire to include data for NICU admissions of infants born \<22 weeks' gestation may also submit these data.

Where it's running

• University of Alabama at Birmingham
  Birmingham, Alabama, United States Recruiting
• University of South Alabama
  Mobile, Alabama, United States Recruiting
• Vallywise Health Medical Center
  Phoenix, Arizona, United States Recruiting
• Loma Linda University Children's Hospital
  Loma Linda, California, United States Recruiting
• Miller Children's & Women's Hospital
  Long Beach, California, United States Recruiting
• Children's Hospital, Orange County
  Orange, California, United States Recruiting

+9 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Principal investigator: Matthew A Rysavy, MD, PhD — The University of Texas Health Science Center, Houston
• Study coordinator: Matthew A Rysavy, MD, PhD
• Email: Matthew.A.Rysavy@uth.tmc.edu
• Phone: 713-500-5651

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UK 22-Week Baby Observation: Learning What Happens for Infants Born at 22 Weeks

  This study simply collects and shares de-identified medical notes about babies born at 22 weeks to see how they are cared for and what outcomes occur.

  Recruiting at 50 sites Imperial College London · Middlesbrough, Teeside and 49 other locations · NCT07616778

• A decision support tool for families facing preterm delivery decisions

  This study is testing a new tool to help families make better decisions about care for their premature babies born between 22 and 26 weeks of pregnancy.

  Recruiting at 12 sites Indiana University · San Diego, California and 11 other locations · NCT05264779

• Single dose of corticosteroids for pregnant individuals at risk of preterm delivery

  This study is testing if a single lower dose of a corticosteroid can help pregnant people at risk of preterm delivery have healthier babies compared to the usual double dose.

  Recruiting at 16 sites Phase 4 McMaster University · Calgary, Alberta and 24 other locations · NCT05114096

• Digitally Enabled Districts 2.0: Aimed at Improving Maternal and Neonatal Care in Garut

  A stepped-wedge trial tests whether an integrated digital health ecosystem helps 45 local clinics in Garut improve the completeness and timeliness of maternal and neonatal care.

  Recruiting Summit Institute for Development, Indonesia · Mataram, West Nusa Tenggara · NCT07842224

• Wireless MicroPremVitals Button Sensor for the NICU

  This study tests a tiny wireless sensor system to monitor heart rate, oxygen, and temperature in extremely preterm babies in the NICU to see if it works safely without wires.

  Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07732257

• Caffeine in pregnancy: how the mother and baby handle it during delivery

  This study tests how caffeine is processed in pregnant people and how much reaches the baby when given shortly before delivery.

  Recruiting Phase 1 Indiana University · Indianapolis, Indiana · NCT07570121

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.